Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.
Company Details
- Employees
- 40
- Founded
- -
- Address
- 38 Jermyn Street, London,uk,sw1y 6dn,united Kingdom
- Phone
- (207) 534-1500
- in****@****rth.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- abingworth.com
- Keywords
- Investing in life sciences.
- HQ
- London, UK
Abingworth Questions
Abingworth's helpline number is (207) 534-1500
Abingworth's website is abingworth.com
Abingworth's LinkedIn profile is https://www.linkedin.com/company/abingworth
Abingworth has
40 employees.
View email and phone details for 40
employees at Abingworth.
Abingworth's industry is
Venture Capital and Private Equity Principals
Abingworth's top competitors are
Syncona Limited,
4bio Capital,
Advent Life Sciences,
Launch Therapeutics,
Mvm Partners,
Sv Health Investors,
Forbion,
Sofinnova Partners,
Novo Holdings,
Orbimed.
Abingworth's support email address is info@abingworth.com
Abingworth's categories are Venture Capital and Private Equity Principals
Abingworth's founding year is 1973
